SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on November 1, 2012, reporting an event that occurred on October 26, 2012. The registrant, India Globalization Capital, Inc., is a Maryland corporation headquartered in Bethesda, Maryland. The filing addresses a regulatory notice regarding the company's stock listing status on the NYSE MKT LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance regarding stock listing standards rather than financial performance data.
Material Changes
The primary material change reported is the receipt of a notice from the NYSE MKT LLC stating that the Company's securities have been trading at a low price per share for a substantial period. Consequently, the Company is now subject to the ".BC" indicator to denote noncompliance with continued listing standards.
Guidance, Outlook, and Risks
- Compliance Requirement: Continued listing is predicated on the Company effecting a reverse stock split of its Common Stock no later than April 26, 2013.
- Listing Status: The Company has been included in a list of issuers not in compliance with Exchange standards until the reverse split is completed and compliance is regained.
- Disclosure: A press release announcing this non-compliance was issued on November 1, 2012, and is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the current share price and trading volume to assess the severity of the "low price" condition.
- Confirm the Company's official plan and timeline for executing the required reverse stock split by the April 26, 2013 deadline.
- Review the attached press release (Exhibit 99.1) for additional management commentary on the situation.
- Monitor subsequent filings for updates on the ".BC" indicator status and any further communications from the NYSE MKT LLC.